此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Safety, Efficacy and Operability of Using the New Tissue Containment System During Laprascopic Hysterectomy

2020年6月8日 更新者:Jing Liang

Safety, Efficacy and Operability of Using the New Tissue Containment System With Hard Pipes Which Can Assemble With Detachable Trocars Seamlessly for Tissue Removal During Laprascopic Hysterectomy

The study is designed to evaluate the safety, operability and efficacy of performing the new tissue containment system during laparoscopic hysterectomy. Pre- and perimenopausal women undergoing laparoscopic hysterectomy.

研究概览

研究类型

介入性

注册 (预期的)

120

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

有资格学习的性别

女性

描述

Inclusion Criteria:

  • Pre- and Peri-menopausal woman patient age 18-65 years
  • Women with fibroids, adenomyosis, and endometrial hyperplasia and indication for laparoscopic hysterectomy.
  • Normal Pap smear result within one year
  • The uterus is larger than 12 weeks of gestation
  • The body mass index of the patients is 18.5-27.9kg/m2
  • Signed informed consent form

Exclusion Criteria:

  • Women with Known or suspected malignancy
  • patients during pregnancy and lactation
  • Known blood diseases, bleeding coagulation disease, any part of the active bleeding or bleeding tendency of the constitution of the patient
  • Patients with known severe liver and kidney dysfunction;Liver function (ALT, AST) ≥ 2 times of normal upper limit, or renal function (Cr) ≥ normal upper limit
  • Patients who are known to have participated in any other clinical trial within 3 months
  • Patients who cannot sign informed consent
  • Patients with acute stage infection of the reproductive system or other sites

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Using the New Tissue Containment System group
using the new tissue containment system during Laparoscopic Hysterectomy. The divice is a soft specimen bag in which the uterus tissue is sealed and quickly morcellation and removed through vagina. The divice is named the new tissue containment system.
Using the new tissue containment system during Laparoscopic hysterectomy. The divice is a soft specimen bag in which the uterus tissue is sealed and quickly morcellation and removed through vagina. The divice is named the new tissue containment system.
无干预:Open group
Without using any procteciton system during Laprascopic Hysterectomy.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The exposure rate
大体时间:approximately two years
Exposure is defined as "disruption of the device (using dye leak testing or water testing) or visible tissue dissemination".
approximately two years

次要结果测量

结果测量
措施说明
大体时间
Mean procedure time
大体时间:Within one day after the surgery
Mean procedure time will be measured by hour/minutes.
Within one day after the surgery
The probability of failure during in-bag morcellation procedure
大体时间:approximately two years
Failure is defined as the operator's inability to successfully insert and extract the device.
approximately two years
Estimated blood loss during operation
大体时间:Within one day after the surgery
Blood loss during operation will be measured by volume (mL)
Within one day after the surgery
Post-operative pain
大体时间:Within one month after the surgery
The patients' post-operative pain will be measured by The Visual Analog Score (VAS).The maximum value is 10 and the minimum is 0. The lower score means a better outcome.
Within one month after the surgery
Rate of intra- or post-operative complications
大体时间:Three months after the surgery
Intra or post complications rate (e.g. urinary, intestinal or nerve injury)
Three months after the surgery
The Surgeon Task Load Index
大体时间:Within one week after the surgery
The Surgery Task Load Index will be measured by questionaire. The maximum value is 120 and the minimum is 0. The higher score means a worse outcome.
Within one week after the surgery
The Patients' life quality postoperative
大体时间:One months after the surgery
The patients' life quality will be measured by The World Health Organization's Quality of Life Questionnaire-Brief Version(WHOQOL-BREF).The maximum value is 120 and the minimum is 0. The higher score means a better outcome.
One months after the surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (预期的)

2020年6月16日

初级完成 (预期的)

2021年6月16日

研究完成 (预期的)

2022年12月26日

研究注册日期

首次提交

2020年5月25日

首先提交符合 QC 标准的

2020年6月8日

首次发布 (实际的)

2020年6月9日

研究记录更新

最后更新发布 (实际的)

2020年6月9日

上次提交的符合 QC 标准的更新

2020年6月8日

最后验证

2020年5月1日

更多信息

与本研究相关的术语

其他研究编号

  • NTCS-LH

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

IPD 计划说明

IPD will to be shared with other researchers after four years

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

the new tissue containment system的临床试验

3
订阅